AQB 8-K
Aquabounty Technologies Inc (AQB)
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________
Form
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
|
|
(State or other jurisdiction | (Commission | (IRS Employer |
(Address of principal executive offices)
(Zip Code)
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report.)
Title of each class | Trading Symbol(s) | Name of exchange on which registered |
The |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02 Results of Operations and Financial Condition.
On November 7, 2023, AquaBounty Technologies, Inc. issued a press release regarding its financial and corporate updates for the quarter ended September 30, 2023. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
The information included in this Current Report on Form 8-K pursuant to Item 2.02, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. |
Exhibit No. |
| Description |
| Press release issued by AquaBounty Technologies, Inc. on November 7, 2023, furnished herewith. | |
104 |
| Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
| AquaBounty Technologies, Inc. |
|
| (Registrant) |
|
|
|
November 7, 2023 |
| /s/ David A. Frank |
|
| David A. Frank |
|
| Chief Financial Officer |
Exhibit 99.1
AquaBounty Technologies Announces Third Quarter 2023 Financial Results
MAYNARD, Mass., November 7, 2023 -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company’s financial results for the third quarter and nine months ended September 30, 2023.
Third Quarter 2023 Highlights and Recent Developments
|
· |
Generated $733 thousand in product revenue in the third quarter, a year-over-year increase of 12% as compared to $653 thousand in the third quarter of 2022; |
|
· |
Net loss in the third quarter of 2023 was $6.1 million, as compared to $5.4 million in the third quarter of 2022; |
|
· |
Cash and cash equivalents and restricted cash totaled $17.8 million as of September 30, 2023, as compared to $102.6 million as of December 31, 2022; and |
|
· |
Entered into a Memorandum of Understanding with Noble Salmon to develop a salmon farm in the country of Georgia. |
Management Commentary
“Our third quarter results were impacted by a decline in market prices for Atlantic salmon that began during the second quarter, even though our Indiana farm exceeded its planned output,” said Sylvia Wulf, Board Chair and Chief Executive Officer of AquaBounty. However, we continue to be encouraged by the demand for our fish.
“We announced in August that the Company was evaluating both the cost estimate and our options for moving forward with the completion of construction of our Ohio farm. We selected Gilbane Building Company (“Gilbane”) as our new construction firm for the project and they have been working for the past several months with the subcontractors on the project to estimate the remaining cost to finish construction of the facility. That work has been completed and the new estimate for the total project cost is now in the range of $485 - $495 million, of which approximately $140 million has been spent to date. We recognize this is substantially higher than previous ranges, but the updated estimates incorporate the highly inflationary environment for labor and materials, particularly concrete and piping, that have impacted construction projects over the last three years. Consistent with our commitment to environmental stewardship, the estimate includes a water/wastewater treatment facility to return water used in the farm to the local environment in an “as clean” condition as when it was withdrawn, and in a manner that meets or exceeds applicable local and federal EPA standards, before it returns to the river. We are negotiating elements of the estimated costs with Gilbane, and once complete, will finalize the Guaranteed Maximum Price that would provide a contractual cap on the total expenditure to complete the farm.
“We are continuing our collaboration with Wells Fargo Corporate and Investment Banking on our plans to place a mix of taxable and tax-exempt bonds through the Toledo-Lucas County Port Authority in an amount up to $425 million, and we are exploring a wide range of alternatives with Oppenheimer & Co. to complete the additional capital requirements to allow construction to resume on the Ohio farm. Though there are significant steps and risks remaining to complete this process, we are excited to be working with our team of collaborators.
“Finally, we continue to make progress on leveraging and expanding our operational expertise internationally. AquaBounty has entered into a non-binding memorandum of understanding with Noble Salmon, a company formed to build and operate a Recirculating Aquaculture System (“RAS”) salmon farm in the Republic of Georgia. Noble Salmon was formed by the Benish Group, whose CEO Meni Benish is also a co-founder of Archi, a major engineering and real estate development firm in the Republic of Georgia. Benish is also the Chairman of the Israel-Georgia Chamber of Commerce. Benish Group will contribute expertise in engineering, material sourcing and permitting to the project, while AquaBounty will provide its experience successfully operating RAS farms through rigorous operating procedures and incorporating the latest technologies into the design of those farms. The combination of capabilities of the two companies benefits the construction and operation of a planned state-of-the-art RAS farm focused on producing Atlantic salmon for sale in nearby markets. This project will be the first instance of AquaBounty executing its strategy to enter additional salmon markets through local partnerships in a capital-lite structure.
“As always, I look forward to providing my fellow shareholders with an update in the near future,” concluded Wulf.
About AquaBounty
At AquaBounty Technologies, Inc. (NASDAQ: AQB), we believe we are a leader in land-based sustainable aquaculture from start to finish. As a vertically integrated Company from broodstock to grow out, we are leveraging decades of expertise in fish breeding, genetics, and health & nutrition to deliver disruptive solutions that address food insecurity and climate change issues. We are committed to feeding the world efficiently, sustainably and profitably. AquaBounty provides fresh Atlantic salmon to nearby markets by raising its fish in carefully monitored land-based fish farms through a safe, secure and sustainable process. The Company’s land-based Recirculating Aquaculture System (“RAS”) farms, including a grow-out farm located in Indiana, United States and a broodstock and egg production farm located on Prince Edward Island, Canada, are close to key consumption markets and are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. AquaBounty is raising nutritious salmon that is free of antibiotics and contaminants and provides a solution resulting in a reduced carbon footprint and no risk of pollution to marine ecosystems as compared to traditional sea-cage farming. For more information on AquaBounty, please visit www.aquabounty.com or follow us on Facebook, Twitter, LinkedIn and Instagram.
Forward-Looking Statements
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995, as amended, including regarding the estimated cost of the Ohio farm and timing of its construction; Ohio farm design and capabilities; timing, terms and completion of the contemplated bond financing; and any other statements regarding the financing of the Ohio farm; and expectations for our partnership with Noble Salmon, such as the construction of a planned RAS farm, the capital structure for the partnership, and the farm’s production and sales. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these statements because they involve significant risks and uncertainties about AquaBounty. AquaBounty may use words such as “continue,” “moving forward,” “believe,” “will,” “may,” the negative forms of these words and similar expressions to identify such forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are, among other things, our ability to continue as a going concern; the potential for additional delays and increased costs related to construction of our new farms and renovations to existing farms; a failure to raise additional capital to finance our activities on acceptable terms; an inability to produce and sell our products in sufficient volume and at acceptable cost and prices; our reliance on partners such as Noble Salmon; any inability to protect our intellectual property and other proprietary rights and technologies; the effect of changes in applicable laws, regulations and policies; our ability to secure any necessary regulatory approvals and permits; the degree of market acceptance of our products; our failure to retain and recruit key personnel; and the price and volatility of our common stock. Forward-looking statements speak only as of the date hereof, and, except as required by law, AquaBounty undertakes no obligation to update or revise these forward-looking statements. For information regarding the risks faced by us, please refer to our public filings with the Securities and Exchange Commission (“SEC”), available on the Investors section of our website at www.aquabounty.com and on the SEC’s website at www.sec.gov.
Company & Investor Contact:
AquaBounty Technologies
Dave Conley
Corporate Communications
(613) 294-3078
Media Contact:
Vince McMorrow
Fahlgren Mortine
(614) 906-1671
[email protected]
Condensed Consolidated Balance Sheets
(Unaudited)
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
2023 |
|
2022 |
||
|
Assets |
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
Cash and cash equivalents |
$ |
16,767,070 |
|
$ |
101,638,557 |
|
Inventory |
|
1,942,420 |
|
|
2,276,592 |
|
Prepaid expenses and other current assets |
|
3,718,087 |
|
|
2,133,583 |
|
Total current assets |
|
22,427,577 |
|
|
106,048,732 |
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
168,657,134 |
|
|
106,286,186 |
|
Right of use assets, net |
|
204,396 |
|
|
222,856 |
|
Intangible assets, net |
|
207,861 |
|
|
218,139 |
|
Restricted cash |
|
1,000,000 |
|
|
1,000,000 |
|
Other assets |
|
49,367 |
|
|
64,859 |
|
Total assets |
$ |
192,546,335 |
|
$ |
213,840,772 |
|
|
|
|
|
|
|
|
Liabilities and stockholders' equity |
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
Accounts payable and accrued liabilities |
$ |
9,895,839 |
|
$ |
12,000,592 |
|
Accrued employee compensation |
|
727,743 |
|
|
1,021,740 |
|
Current debt |
|
756,559 |
|
|
2,387,231 |
|
Other current liabilities |
|
4,540 |
|
|
20,830 |
|
Total current liabilities |
|
11,384,681 |
|
|
15,430,393 |
|
|
|
|
|
|
|
|
Long-term lease obligations |
|
199,856 |
|
|
203,227 |
|
Long-term debt, net |
|
7,772,695 |
|
|
6,286,109 |
|
Total liabilities |
|
19,357,232 |
|
|
21,919,729 |
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
Common stock, $0.001 par value, 75,000,000 and 150,000,000 shares authorized at |
|
|
|
|
|
|
September 30, 2023 and December 31, 2022, respectively; 3,846,772 and 3,834,383 |
|
|
|
|
|
|
shares outstanding at September 30, 2023 and December 31, 2022, respectively |
|
3,847 |
|
|
3,834 |
|
Additional paid-in capital |
|
385,879,364 |
|
|
385,455,961 |
|
Accumulated other comprehensive loss |
|
(539,204) |
|
|
(516,775) |
|
Accumulated deficit |
|
(212,154,904) |
|
|
(193,021,977) |
|
Total stockholders' equity |
|
173,189,103 |
|
|
191,921,043 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity |
$ |
192,546,335 |
|
$ |
213,840,772 |
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
|
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues |
$ |
733,133 |
|
$ |
653,432 |
|
$ |
1,919,409 |
|
$ |
2,686,019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Product costs |
|
4,096,040 |
|
|
3,518,296 |
|
|
11,446,158 |
|
|
10,044,092 |
|
Sales and marketing |
|
191,862 |
|
|
186,393 |
|
|
584,401 |
|
|
783,882 |
|
Research and development |
|
184,221 |
|
|
220,598 |
|
|
485,532 |
|
|
596,079 |
|
General and administrative |
|
2,334,861 |
|
|
2,264,755 |
|
|
8,402,876 |
|
|
7,472,921 |
|
Total costs and expenses |
|
6,806,984 |
|
|
6,190,042 |
|
|
20,918,967 |
|
|
18,896,974 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
(6,073,851) |
|
|
(5,536,610) |
|
|
(18,999,558) |
|
|
(16,210,955) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense |
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
(63,746) |
|
|
(72,313) |
|
|
(195,809) |
|
|
(222,295) |
|
Other (expense) income, net |
|
(516) |
|
|
168,796 |
|
|
62,440 |
|
|
345,355 |
|
Total other (expense) income |
|
(64,262) |
|
|
96,483 |
|
|
(133,369) |
|
|
123,060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
$ |
(6,138,113) |
|
$ |
(5,440,127) |
|
$ |
(19,132,927) |
|
$ |
(16,087,895) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation loss |
|
(138,202) |
|
|
(303,725) |
|
|
(22,429) |
|
|
(374,422) |
|
Unrealized gain on marketable securities |
|
— |
|
|
32,370 |
|
|
— |
|
|
40,101 |
|
Total other comprehensive loss |
|
(138,202) |
|
|
(271,355) |
|
|
(22,429) |
|
|
(334,321) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss |
$ |
(6,276,315) |
|
$ |
(5,711,482) |
|
$ |
(19,155,356) |
|
$ |
(16,422,216) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted net loss per share |
$ |
(1.60) |
|
$ |
(1.42) |
|
$ |
(4.98) |
|
$ |
(4.20) |
|
Weighted average number of Common Shares - |
|
|
|
|
|
|
|
|
|
|
|
|
basic and diluted |
|
3,846,622 |
|
|
3,833,430 |
|
|
3,843,349 |
|
|
3,832,328 |
Condensed Consolidated Statements of Cash Flows
(Unaudited)
|
|
|
|
|
|
|
|
|
Nine Months Ended |
||||
|
|
2023 |
|
2022 |
||
|
Operating activities |
|
|
|
|
|
|
Net loss |
$ |
(19,132,927) |
|
$ |
(16,087,895) |
|
Adjustment to reconcile net loss to net cash used in |
|
|
|
|
|
|
operating activities: |
|
|
|
|
|
|
Depreciation and amortization |
|
1,607,260 |
|
|
1,501,381 |
|
Share-based compensation |
|
423,416 |
|
|
426,249 |
|
Other non-cash charge |
|
13,087 |
|
|
18,997 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
Inventory |
|
332,314 |
|
|
(857,331) |
|
Prepaid expenses and other assets |
|
(1,570,255) |
|
|
(2,475,197) |
|
Accounts payable and accrued liabilities |
|
158,108 |
|
|
(369,254) |
|
Accrued employee compensation |
|
(293,997) |
|
|
(109,841) |
|
Net cash used in operating activities |
|
(18,462,994) |
|
|
(17,952,891) |
|
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
Purchases of and deposits on property, plant and equipment |
|
(66,256,590) |
|
|
(44,882,996) |
|
Maturities of marketable securities |
|
— |
|
|
149,435,173 |
|
Purchases of marketable securities |
|
— |
|
|
(47,621,291) |
|
Other investing activities |
|
(3,263) |
|
|
12,500 |
|
Net cash (used in) provided by investing activities |
|
(66,259,853) |
|
|
56,943,386 |
|
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
Proceeds from issuance of debt |
|
394,156 |
|
|
42,338 |
|
Repayment of term debt |
|
(542,019) |
|
|
(478,870) |
|
Proceeds from the exercise of stock options and warrants |
|
— |
|
|
1,538 |
|
Net cash used in financing activities |
|
(147,863) |
|
|
(434,994) |
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
(777) |
|
|
(1,869) |
|
Net change in cash, cash equivalents and restricted cash |
|
(84,871,487) |
|
|
38,553,632 |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
102,638,557 |
|
|
89,454,988 |
|
Cash, cash equivalents and restricted cash at end of period |
$ |
17,767,070 |
|
$ |
128,008,620 |
|
|
|
|
|
|
|
|
Reconciliation of cash, cash equivalents and restricted cash reported |
|
|
|
|
|
|
in the consolidated balance sheet: |
|
|
|
|
|
|
Cash and cash equivalents |
$ |
16,767,070 |
|
$ |
127,008,620 |
|
Restricted cash |
|
1,000,000 |
|
|
1,000,000 |
|
Total cash, cash equivalents and restricted cash |
$ |
17,767,070 |
|
$ |
128,008,620 |
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information and non-cash transactions: |
|
|
|
|
|
|
Interest paid in cash |
$ |
184,497 |
|
$ |
209,666 |
|
Property and equipment included in accounts payable and accrued liabilities |
$ |
8,300,093 |
|
$ |
14,496,747 |